Semaglutide – the drug in medicines like Ozempic and Wegovy – causes mice to train much less. The discovering suggests these weight-loss medicines could cut back folks’s motivation to work out.
Semaglutide helps deal with sort 2 diabetes and weight problems by mimicking a hormone known as GLP-1, which regulates blood sugar and suppresses urge for food. GLP-1 additionally dampens exercise within the mind areas concerned in reward processing and cravings. This will likely clarify why folks on semaglutide-based medicines don’t discover consuming as rewarding or pleasurable as they did earlier than taking the medicine. Additionally, it’s most likely why some research have indicated semaglutide would possibly assist deal with substance use problems as nicely.
Ralph DiLeone at Yale College and his colleagues needed to know whether or not semaglutide impacts different rewarding behaviours too, corresponding to train – which is understood to enhance temper and reminiscence. In order that they handled seven mice with semaglutide and an equal quantity with a placebo for every week and measured how far the animals ran on an train wheel every day.
On common, these handled with semaglutide ran about half the space of these given a placebo, suggesting they could have a decrease motivation to train.
To additional validate this, the researchers handled a separate group of 15 mice with semaglutide and one other equal-sized group with a placebo for 5 days and explored their willingness to train on a wheel. Nonetheless, this time, the train wheel periodically locked up whereas the animals had been working on it. To unlock it, the mice needed to press a lever with their nostril. Every time the wheel locked, it grew to become progressively tougher to unlock, requiring the mice to press the lever extra instances. “Ultimately they give up,” says DiLeone, who introduced these findings at a Society for Neuroscience assembly in Chicago on 7 October. “We name that their break level, and it offers us a surrogate for the way motivated they’re to entry working wheels.”
The utmost variety of instances mice handled with semaglutide pressed the lever was, on common, 25 per cent lower than that of animals within the management group. The researchers repeated the experiment with overweight mice and located comparable outcomes.
Collectively, these findings recommend that semaglutide-based medicines corresponding to Ozempic or Wegovy could cut back motivation to train, much like how they cut back cravings for meals or medicine. Nonetheless, there hasn’t been any proof indicating that that is the case in folks, says DiLeone. This can be as a result of most information on Wegovy and Ozempic comes from folks enrolled in weight reduction programmes that embody train, he says.
Nonetheless, these findings underscore the potential of those medicine to intrude with constructive behaviours, not simply unfavorable ones.“[This] information suggests there are nonetheless motivated behaviours that could be altered [with semaglutide] that we haven’t requested about but,” says Karolina Skibicka at The Pennsylvania State College.
Matters: